NPVAC2

N/A

Report date: 2022/11/24 09:31:30

Base Information

Drug NameNPVAC2
Drug Alias NameNPVAC2+Poly-ICLCNeoPep Vaccine2 plus Poly-ICLCNPVAC-2
ClassificationVaccines > Development/production technology > Synthetic peptide vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsGlioma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesShanghai Tenth People'S Hospital
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Tenth People'S Hospital
Inactive CompaniesN/A
Active IndicationsGlioma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A